Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

The cost of safe sex: estimating the price premium for unprotected sex during the Avahan HIV prevention programme in India.

Quaife M, Lépine A, Deering K, Terris-Prestholt F, Beattie T, Isac S, Paranjape RS, Vickerman P.

Health Policy Plan. 2019 Oct 11. pii: czz100. doi: 10.1093/heapol/czz100. [Epub ahead of print]

PMID:
31603470
2.

HIV-1-Mediated Suppression of IFN-α Production Is Associated with Inhibition of IRF-7 Translocation and PI3K/akt Pathway in Plasmacytoid Dendritic Cells.

Dhamanage AS, Thakar MR, Paranjape RS.

AIDS Res Hum Retroviruses. 2019 Jan;35(1):40-48. doi: 10.1089/AID.2018.0136. Epub 2018 Sep 15.

PMID:
30073840
3.

An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.

Phukan SK, Medhi GK, Mahanta J, Adhikary R, Thongamba G, Paranjape RS, Akoijam BS.

Harm Reduct J. 2017 Jul 3;14(1):41. doi: 10.1186/s12954-017-0171-0.

4.

Discordant HIV DNA PCR results among infants diagnosed with HIV infection and initiated on ART: a case series.

Jagtap DD, Gawde NC, Kamble SV, Sharma AP, Paranjape RS.

Int J STD AIDS. 2017 Mar;28(4):415-417. doi: 10.1177/0956462416669852. Epub 2016 Sep 27.

PMID:
27638411
5.

Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India.

Karade SK, Ghate MV, Chaturbhuj DN, Kadam DB, Shankar S, Gaikwad N, Gurav S, Joshi R, Sane SS, Kulkarni SS, Kurle SN, Paranjape RS, Rewari BB, Gangakhedkar RR.

Medicine (Baltimore). 2016 Sep;95(37):e4886. doi: 10.1097/MD.0000000000004886.

6.

HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in India.

Godbole SV, Nandy K, Gauniyal M, Nalawade P, Sane S, Koyande S, Toyama J, Hegde A, Virgo P, Bhatia K, Paranjape RS, Risbud AR, Mbulaiteye SM, Mitsuyasu RT.

Medicine (Baltimore). 2016 Sep;95(37):e4850. doi: 10.1097/MD.0000000000004850.

7.

HIV/AIDS in India: an overview of the Indian epidemic.

Paranjape RS, Challacombe SJ.

Oral Dis. 2016 Apr;22 Suppl 1:10-4. doi: 10.1111/odi.12457. Review.

PMID:
27109267
8.

Short Communication: Phylogenetic and Molecular Characterization of Six Full-Length HIV-1 Genomes from India Reveals a Monophyletic Lineage of Indian Sub-Subtype A1.

Pandey SS, Cherian S, Thakar M, Paranjape RS.

AIDS Res Hum Retroviruses. 2016 May;32(5):489-502. doi: 10.1089/AID.2015.0207. Epub 2016 Feb 11.

PMID:
26756665
9.

Outcome of patients on second line antiretroviral therapy under programmatic condition in India.

Chakravarty J, Sundar S, Chourasia A, Singh PN, Kurle S, Tripathy SP, Chaturbhuj DN, Rai M, Agarwal AK, Mishra RN, Paranjape RS.

BMC Infect Dis. 2015 Nov 14;15:517. doi: 10.1186/s12879-015-1270-8.

10.

Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Kee PN, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW.

PLoS Med. 2015 Jun 1;12(6):e1001845. doi: 10.1371/journal.pmed.1001845. eCollection 2015 Jun. No abstract available.

11.

Sudarshan Kriya yoga improves quality of life in healthy people living with HIV (PLHIV): results from an open label randomized clinical trial.

Mawar N, Katendra T, Bagul R, Bembalkar S, Vedamurthachar A, Tripathy S, Srinivas K, Mandar K, Kumar N, Gupte N, Paranjape RS.

Indian J Med Res. 2015 Jan;141(1):90-9.

12.

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, Rinke de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW.

PLoS Med. 2015 Apr 7;12(4):e1001810. doi: 10.1371/journal.pmed.1001810. eCollection 2015 Apr. Erratum in: PLoS Med. 2015 Jun;12(6):e1001845.

13.

Female sex worker's participation in the community mobilization process: two distinct forms of participations and associated contextual factors.

Nagarajan K, Sahay S, Mainkar MK, Deshpande S, Ramesh S, Paranjape RS.

BMC Public Health. 2014 Dec 24;14:1323. doi: 10.1186/1471-2458-14-1323.

14.

Inconsistent condom use by male clients during anal intercourse with occasional and regular female sex workers (FSWs): survey findings from southern states of India.

Ramanathan S, Nagarajan K, Ramakrishnan L, Mainkar MK, Goswami P, Yadav D, Sen S, George B, Rachakulla H, Subramanian T, Paranjape RS.

BMJ Open. 2014 Nov 19;4(11):e005166. doi: 10.1136/bmjopen-2014-005166.

15.

Undiagnosed HIV among people who inject drugs in Manipur, India.

Armstrong G, Medhi GK, Mahanta J, Paranjape RS, Kermode M.

AIDS Care. 2015;27(3):288-92. doi: 10.1080/09540121.2014.972322. Epub 2014 Oct 27.

PMID:
25345544
16.

Prevalence of anal human papillomavirus infection among HIV-infected women from India.

Godbole SV, Mane AK, Chidrawar SR, Katti UR, Kalgutkar S, Athavale PV, Pawar JS, Ratnaparkhi MM, Alexander M, Risbud AR, Paranjape RS.

J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):e111-4. doi: 10.1097/QAI.0000000000000328. No abstract available.

PMID:
25171734
17.

Assessment of the population-level effectiveness of the Avahan HIV-prevention programme in South India: a preplanned, causal-pathway-based modelling analysis.

Pickles M, Boily MC, Vickerman P, Lowndes CM, Moses S, Blanchard JF, Deering KN, Bradley J, Ramesh BM, Washington R, Adhikary R, Mainkar M, Paranjape RS, Alary M.

Lancet Glob Health. 2013 Nov;1(5):e289-99. doi: 10.1016/S2214-109X(13)70083-4. Epub 2013 Sep 30.

18.

Increase in condom use and decline in prevalence of sexually transmitted infections among high-risk men who have sex with men and transgender persons in Maharashtra, India: Avahan, the India AIDS Initiative.

Ramanathan S, Deshpande S, Gautam A, Pardeshi DB, Ramakrishnan L, Goswami P, Adhikary R, George B, Paranjape RS, Mainkar MM.

BMC Public Health. 2014 Aug 3;14:784. doi: 10.1186/1471-2458-14-784.

19.

Emergence of drug resistance in human immunodeficiency virus type 1 infected patients from pune, India, at the end of 12 months of first line antiretroviral therapy initiation.

Patil RT, Gupta RM, Sen S, Tripathy SP, Chaturbhuj DN, Hingankar NK, Paranjape RS.

ISRN AIDS. 2014 Apr 10;2014:674906. doi: 10.1155/2014/674906. eCollection 2014.

20.

Retention of antiretroviral naïve patients registered in HIV care in a program clinic in Pune, India.

Ghate MV, Zirpe SS, Gurav NP, Rewari BB, Gangakhedkar RR, Paranjape RS.

Indian J Sex Transm Dis AIDS. 2014 Jul-Dec;35(2):124-8. doi: 10.4103/0253-7184.142407.

21.

An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India.

Goswami P, Medhi GK, Armstrong G, Setia MS, Mathew S, Thongamba G, Ramakrishnan L, George B, Singh RK, Paranjape RS, Mahanta J.

Int J Drug Policy. 2014 Sep;25(5):853-64. doi: 10.1016/j.drugpo.2014.04.016. Epub 2014 May 28.

22.

Higher Expression of Activating Receptors on Cytotoxic NK Cells is Associated with Early Control on HIV-1C Multiplication.

Kulkarni AG, Paranjape RS, Thakar MR.

Front Immunol. 2014 May 16;5:222. doi: 10.3389/fimmu.2014.00222. eCollection 2014.

23.

Early ART in infants may hold secrets for HIV cure.

Paranjape RS.

Med J Armed Forces India. 2013 Oct;69(4):317-8. doi: 10.1016/j.mjafi.2013.09.006. No abstract available.

24.

Evaluation of a cost effective in-house method for HIV-1 drug resistance genotyping using plasma samples.

Chaturbhuj DN, Nirmalkar AP, Paranjape RS, Tripathy SP.

PLoS One. 2014 Feb 12;9(2):e87441. doi: 10.1371/journal.pone.0087441. eCollection 2014.

25.

Is cure of HIV infection in sight?

Shete A, Paranjape RS.

Indian J Med Res. 2013 Dec;138(6):824-8. No abstract available.

26.

Association between alcohol use and HIV-related sexual risk behaviors among men who have sex with men (MSM): findings from a multi-site bio-behavioral survey in India.

Yadav D, Chakrapani V, Goswami P, Ramanathan S, Ramakrishnan L, George B, Sen S, Subramanian T, Rachakulla H, Paranjape RS.

AIDS Behav. 2014 Jul;18(7):1330-8. doi: 10.1007/s10461-014-0699-x.

27.

Prevalence of drug resistance in human immunodeficiency virus type 1-infected treatment-naive children in Pune, India.

Kumar M, Sen S, Gupta RK, Chaturbhuj D, Tripathy SP, Paranjape RS.

AIDS Res Hum Retroviruses. 2014 Mar;30(3):294-8. doi: 10.1089/AID.2013.0222. Epub 2014 Feb 7.

28.

Increasing condom use and declining STI prevalence in high-risk MSM and TGs: evaluation of a large-scale prevention program in Tamil Nadu, India.

Subramanian T, Ramakrishnan L, Aridoss S, Goswami P, Kanguswami B, Shajan M, Adhikary R, Purushothaman GK, Ramamoorthy SK, Chinnaswamy E, Veeramani IB, Paranjape RS.

BMC Public Health. 2013 Sep 17;13:857. doi: 10.1186/1471-2458-13-857.

29.

Differential modulation of phenotypic composition of HIV-infected and -uninfected PBMCs during cryopreservation.

Shete A, Jayawant P, Thakar M, Kurle S, Singh DP, Paranjape RS.

J Immunoassay Immunochem. 2013;34(4):333-45. doi: 10.1080/15321819.2012.741087.

PMID:
23859784
30.

Exposure to HIV prevention programmes associated with improved condom use and uptake of HIV testing by female sex workers in Nagaland, Northeast India.

Armstrong G, Medhi GK, Kermode M, Mahanta J, Goswami P, Paranjape R.

BMC Public Health. 2013 May 15;13:476. doi: 10.1186/1471-2458-13-476.

31.

An assessment of a large-scale HIV prevention programme for high-risk men who have sex with men and transgenders in Andhra Pradesh, India: using data from routine programme monitoring and repeated cross-sectional surveys.

Goswami P, Rachakulla HK, Ramakrishnan L, Mathew S, Ramanathan S, George B, Adhikary R, Kodavalla V, Rajkumar H, Paranjape RS, Brahmam GN.

BMJ Open. 2013 Apr 8;3(4). pii: e002183. doi: 10.1136/bmjopen-2012-002183. Print 2013.

32.

Syphilis infection among female sex workers in Nagaland, Northeast India: analysing their vulnerability to the infection.

Medhi GK, Mahanta J, Hazarika I, Armstrong G, Adhikary R, Mainkar M, Paranjape RS.

Int J STD AIDS. 2013 Mar;24(3):193-7. doi: 10.1177/0956462412472427. Epub 2013 May 6.

PMID:
23514833
33.

Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.

Chaturbhuj DN, Deshmukh PS, Hingankar NK, Siddhaarth K, Deshpande SN, Sen S, Kabra S, Paranjape RS, Tripathy SP.

J Virol Methods. 2013 Apr;189(1):87-92. doi: 10.1016/j.jviromet.2013.01.001. Epub 2013 Jan 23.

PMID:
23353551
34.

Factors Associated with Use of Latex Condom-Compatible Lubricants by Men Who Have Sex with Men in India: Implications for HIV Prevention.

Ramanathan S, Chakrapani V, Ramakrishnan L, Goswami P, Yadav D, George B, Sen S, Rachakulla H, Subramanian T, Paranjape RS.

J Sex Transm Dis. 2013;2013:161085. doi: 10.1155/2013/161085. Epub 2013 Jun 13.

35.

Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India.

Hingankar NK, Thorat SR, Deshpande A, Rajasekaran S, Chandrasekar C, Kumar S, Srikantiah P, Chaturbhuj DN, Datkar SR, Deshmukh PS, Kulkarni SS, Sane S, Reddy DC, Garg R, Jordan MR, Kabra S, Tripathy SP, Paranjape RS.

Clin Infect Dis. 2012 May;54 Suppl 4:S348-54. doi: 10.1093/cid/cis005.

36.

Factors associated with history of drug use among female sex workers (FSW) in a high HIV prevalence state of India.

Medhi GK, Mahanta J, Kermode M, Paranjape RS, Adhikary R, Phukan SK, Ngully P.

BMC Public Health. 2012 Apr 5;12:273. doi: 10.1186/1471-2458-12-273.

37.

Heading towards the Safer Highways: an assessment of the Avahan prevention programme among long distance truck drivers in India.

Pandey A, Mishra RM, Sahu D, Benara SK, Sengupta U, Paranjape RS, Gautam A, Lenka SR, Adhikary R.

BMC Public Health. 2011 Dec 29;11 Suppl 6:S15. doi: 10.1186/1471-2458-11-S6-S15.

38.

Targeted interventions of the Avahan program and their association with intermediate outcomes among female sex workers in Maharashtra, India.

Mainkar MM, Pardeshi DB, Dale J, Deshpande S, Khazi S, Gautam A, Goswami P, Adhikary R, Ramanathan S, George B, Paranjape RS.

BMC Public Health. 2011 Dec 29;11 Suppl 6:S2. doi: 10.1186/1471-2458-11-S6-S2.

39.

Establishment of reference CD4+ T cell values for adult Indian population.

Thakar MR, Abraham PR, Arora S, Balakrishnan P, Bandyopadhyay B, Joshi AA, Devi KR, Vasanthapuram R, Vajpayee M, Desai A, Mohanakrishnan J, Narain K, Ray K, Patil SS, Singh R, Singla A, Paranjape RS.

AIDS Res Ther. 2011 Oct 3;8:35. doi: 10.1186/1742-6405-8-35.

40.

Factors associated with HIV among female sex workers in a high HIV prevalent state of India.

Medhi GK, Mahanta J, Paranjape RS, Adhikary R, Laskar N, Ngully P.

AIDS Care. 2012;24(3):369-76. doi: 10.1080/09540121.2011.608787. Epub 2011 Sep 9.

PMID:
21902571
41.

T-cell Epitopes Identified by BALB/c Mice Immunized with Vaccinia Expressing HIV-1 Gag lie within immunodominant Regions Recognized by HIV-infected Indian Patients.

Shete AV, Thakar MR, Tripathy SP, Raut C, Chakrabarti S, Paranjape RS.

J Glob Infect Dis. 2011 Jul;3(3):246-53. doi: 10.4103/0974-777X.83530.

42.

Surveillance of transmitted HIV type 1 drug resistance among HIV type 1-positive women attending an antenatal clinic in Kakinada, India.

Thorat SR, Chaturbhuj DN, Hingankar NK, Chandrasekhar V, Koppada R, Datkar SR, Srikantiah P, Garg R, Kabra S, Haldar P, Reddy DC, Bachani D, Tripathy SP, Paranjape RS.

AIDS Res Hum Retroviruses. 2011 Dec;27(12):1291-7. doi: 10.1089/aid.2011.0036. Epub 2011 Jun 28.

PMID:
21568760
43.

Transmitted HIV drug resistance among HIV-infected voluntary counseling and testing centers (VCTC) clients in Mumbai, India.

Chaturbhuj DN, Hingankar NK, Srikantiah P, Garg R, Kabra S, Deshmukh PS, Jadhav SD, Thorat SR, Datkar SR, Mehta P, Ingole N, Mathur M, Ramachandran A, Haldar P, Reddy DC, Bachani D, Rao S, Tripathy SP, Paranjape RS.

AIDS Res Hum Retroviruses. 2010 Aug;26(8):927-32. doi: 10.1089/aid.2010.0032.

PMID:
20704495
44.

Programme coverage, condom use and STI treatment among FSWs in a large-scale HIV prevention programme: results from cross-sectional surveys in 22 districts in southern India.

Ramakrishnan L, Gautam A, Goswami P, Kallam S, Adhikary R, Mainkar MK, Ramesh BM, Morineau G, George B, Paranjape RS.

Sex Transm Infect. 2010 Feb;86 Suppl 1:i62-8. doi: 10.1136/sti.2009.038760.

45.

One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India.

Gupta A, Saple DG, Nadkarni G, Shah B, Vaidya S, Hingankar N, Chaturbhuj D, Deshmukh P, Walshe L, Hudelson SE, James M, Paranjape RS, Eshleman SH, Tripathy S.

AIDS Res Hum Retroviruses. 2010 Jan;26(1):25-31. doi: 10.1089/aid.2009.0102.

46.

Human immunodeficiency virus type 1 gp 41 mutations in proviral DNA among antiretroviral treatment-naive individuals from India.

Sen S, Tripathy SP, Sahni AK, Gupta RM, Kapila K, Chopra GS, Chimanpure VM, Patil AA, Paranjape RS.

AIDS Res Hum Retroviruses. 2009 May;25(5):521-3. doi: 10.1089/aid.2008.0244.

PMID:
19400735
47.

Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India.

Kulkarni SS, Lapedes A, Tang H, Gnanakaran S, Daniels MG, Zhang M, Bhattacharya T, Li M, Polonis VR, McCutchan FE, Morris L, Ellenberger D, Butera ST, Bollinger RC, Korber BT, Paranjape RS, Montefiori DC.

Virology. 2009 Mar 15;385(2):505-20. doi: 10.1016/j.virol.2008.12.032. Epub 2009 Jan 23.

48.

Risk behaviour, sexually transmitted infections and HIV among long-distance truck drivers: a cross-sectional survey along national highways in India.

Pandey A, Benara SK, Roy N, Sahu D, Thomas M, Joshi DK, Sengupta U, Paranjape RS, Bhalla A, Prakash A; IBBA Study Team.

AIDS. 2008 Dec;22 Suppl 5:S81-90. doi: 10.1097/01.aids.0000343766.00573.15.

PMID:
19098482
49.

HIV, sexually transmitted infections and sexual behaviour of male clients of female sex workers in Andhra Pradesh, Tamil Nadu and Maharashtra, India: results of a cross-sectional survey.

Subramanian T, Gupte MD, Paranjape RS, Brahmam GN, Ramakrishnan L, Adhikary R, Kangusamy B, Thomas BE, Kallam S, Girish CP; IBBA Study Team.

AIDS. 2008 Dec;22 Suppl 5:S69-79. doi: 10.1097/01.aids.0000343765.00573.ce.

PMID:
19098481
50.

Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.

Mahanta J, Medhi GK, Paranjape RS, Roy N, Kohli A, Akoijam BS, Dzuvichu B, Das HK, Goswami P, Thongamba G; IBBA study team.

AIDS. 2008 Dec;22 Suppl 5:S59-68. doi: 10.1097/01.aids.0000343764.62455.9e.

PMID:
19098480

Supplemental Content

Loading ...
Support Center